Elanco Confirms Date and Conference Call for First Quarter 2021 Financial Results Announcement
Get Alerts ELAN Hot Sheet
Join SI Premium – FREE
GREENFIELD, Ind.--(BUSINESS WIRE)-- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2021 financial results on Friday, May 7, 2021. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance.
The conference call will begin at 8:00 a.m. eastern time. Investors, media and the general public can access a live webcast of the conference call through the link that will be posted on Elanco’s website at https://investor.elanco.com/events-and-presentations/default.aspx. A replay will also be available on the website shortly following the call.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ ESG/Sustainability framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210407005148/en/
Investor: Tiffany Kanaga +1.302.897.0668 [email protected]
Media: Colleen Parr Dekker +1.317.989.7011 [email protected]
Source: Elanco Animal Health Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Globe Life Inc. Investors to Inquire About Securities Class Action Investigation – GL
- ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation – LFCR, LNDC
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!